Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans

Clinical Genetics

Volumn 79, Issue 6, 2011, Pages 575-581

  Brunham, L R ^a   Tietjen, I ^b   Bochem, A E ^c   Singaraja, R R ^a,b   Franchini, P L ^b   Radomski, C ^b   Mattice, M ^b   Legendre, A ^b   Hovingh, G K ^c   Kastelein, J J P ^c   Hayden, M R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Xenon Pharmaceuticals Inc   (Canada)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Atherosclerosis; HDL; Lipids; Lipoproteins; SR BI

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SCAVENGER RECEPTOR BI;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN EXPERIMENT; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

ADOLESCENT; ADULT; AGED; ANIMALS; BASE SEQUENCE; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CONSERVED SEQUENCE; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC ASSOCIATION STUDIES; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PEDIGREE; PROTEIN STRUCTURE, TERTIARY; SCAVENGER RECEPTORS, CLASS B; SEQUENCE ALIGNMENT; YOUNG ADULT;

MUS;

EID: 79955597630     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2011.01682.x     Document Type: Article

References (30)

1. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996: 271: 518-520.
2. Van Eck M, Pennings M, Hoekstra M, Out R, Van Berkel TJ. Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis. Curr Opin Lipidol 2005: 16: 307-315.
3. Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA 1997: 94: 12610-12615.
4. Varban ML, Rinninger F, Wang N et al. Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Proc Natl Acad Sci USA 1998: 95: 4619-4624.
5. Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER, Krieger M. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 1997: 387: 414-417.
6. Ueda Y, Royer L, Gong E et al. Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J Biol Chem 1999: 274: 7165-7171.
7. Zhang Y, Da Silva JR, Reilly M, Billheimer JT, Rothblat GH, Rader DJ. Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J Clin Invest 2005: 115: 2870-2874.
8. Trigatti B, Rayburn H, Vinals M et al. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci USA 1999: 96: 9322-9327.
9. Van Eck M, Twisk J, Hoekstra M et al. Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver. J Biol Chem 2003: 278: 23699-23705.
10. Hsu LA, Ko YL, Wu S et al. Association between a novel 11-base pair deletion mutation in the promoter region of the scavenger receptor class B type I gene and plasma HDL cholesterol levels in Taiwanese Chinese. Arterioscler Thromb Vasc Biol 2003: 23: 1869-1874.
11. Acton S, Osgood D, Donoghue M et al. Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol 1999: 19: 1734-1743.
12. Osgood D, Corella D, Demissie S et al. Genetic variation at the scavenger receptor class B type I gene locus determines plasma lipoprotein concentrations and particle size and interacts with type 2 diabetes: the framingham study. J Clin Endocrinol Metab 2003: 88: 2869-2879.
13. Morabia A, Ross BM, Costanza MC et al. Population-based study of SR-BI genetic variation and lipid profile. Atherosclerosis 2004: 175: 159-168.
14. McCarthy JJ, Lewitzky S, Reeves C et al. Polymorphisms of the HDL receptor gene associated with HDL cholesterol levels in diabetic kindred from three populations. Hum Hered 2003: 55: 163-170.
15. Hong SH, Kim YR, Yoon YM, Min WK, Chun SI, Kim JQ. Association between HaeIII polymorphism of scavenger receptor class B type I gene and plasma HDL-cholesterol concentration. Ann Clin Biochem 2002: 39: 478-481.
16. Teslovich TM, Musunuru K, Smith AV et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010: 466: 707-713.
17. Vergeer M, Korporaal SJ, Franssen R et al. Genetic variant of the scavenger receptor BI in humans. N Engl J Med 2011: 364: 136-145.
18. Rogler G, Trumbach B, Klima B, Lackner KJ, Schmitz G. HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients. Arterioscler Thromb Vasc Biol 1995: 15: 683-690.
19. Sunyaev S, Ramensky V, Koch I, Lathe W, 3rd, Kondrashov AS, Bork P. Prediction of deleterious human alleles. Hum Mol Genet 2001: 10: 591-597.
20. Brunham LR, Singaraja RR, Pape TD, Kejariwal A, Thomas PD, Hayden MR. Accurate prediction of the functional significance of single nucleotide polymorphisms and mutations in the ABCA1 gene. PLoS Genet 2005: 1: e83.
21. Holleboom AG, Vergeer M, Hovingh GK, Kastelein JJ, Kuivenhoven JA. The value of HDL genetics. Current Opin Lipidol 2008: 19: 385-394.
22. Brunham LR, Singaraja RR, Hayden MR. Variations on a gene: rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis. Annu Rev Nutr 2006: 26: 105-129.
23. Brooks-Wilson A, Marcil M, Clee SM et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999: 22: 336-345.
24. Norum RA, Lakier JB, Goldstein S et al. Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease. N Engl J Med 1982: 306: 1513-1519.
25. Norum KR, Gjone E. Familial serum-cholesterol esterification failure. A new inborn error of metabolism. Biochim Biophys Acta 1967: 144: 698-700.
26. Inazu A, Brown ML, Hesler CB et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 1990: 323: 1234-1238.
27. Singaraja RR, Brunham LR, Visscher H, Kastelein JJ, Hayden MR. Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 2003: 23: 1322-1332.
28. Zannis VI, Chroni A, Krieger M. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J Mol Med 2006: 84: 276-294.
29. Zhao Y, Pennings M, Hildebrand RB et al. Enhanced foam cell formation, atherosclerotic lesion development, and inflammation by combined deletion of ABCA1 and SR-BI in Bone marrow-derived cells in LDL receptor knockout mice on western-type diet. Circ Res 2010: 107: e20-e31.
30. Silver DL. A carboxyl-terminal PDZ-interacting domain of scavenger receptor B, type I is essential for cell surface expression in liver. J Biol Chem 2002: 277: 34042-34047.